Product Name: Lucitanib(E-3810) Request E-3810
Price of E-3810
please inquire via firstname.lastname@example.org
or Fax: 1-201-884-1288
Lucitanib, also known as E-3810, is a novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity. VEGFR/FGFR dual kinase inhibitor E-3810 inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor tyrosine kinases that may be upregulated in various tumor cell types. E-3810 is a potent dual inhibitor of VEGFR and FGFR.
Solubility:Soluble in DMSO
Storage Conditions: 2ºC to 8 ºC, or -20ºC for 3 years.